[1] ZHU H D,GUO J H,MAO A W,et al.Conventional stents versus stents loaded with125iodine seeds for the treatment of unresectable oesophageal cancer:a multicentre,randomised phase 3 trial[J].Lancet Oncol,2014,15(6):612-619.
[2] LIU N,LIU S,XIANG C,et al.Radioactive self-expanding stents give superior palliation in patients with unresectable cancer of the esophagus but should be used with caution if they have had prior radiotherapy[J].Ann Thorac Surg,2014,98(2):521-526.
[3] IWASAKI H,MIZUSHIMA T,SUZUKI Y,et al.Factors that affect stent-related complications in patients with malignant obstruction of the esophagus or gastric cardia[J].Gut Liver,2017,11(1):47-54.
[4] OGILVIE A L,DRONFIELD M W,FERGUSON R,et al.Palliative intubation of oesophagogastric neoplasms at fibreoptic endoscopy[J].Gut,1982,23(12):1060-1067.
[5] PENNATHUR A,GIBSON M K,JOBE B A,et al.Oesophageal carcinoma[J].Lancet,2013,381(9864):400-412.
[6] AJANI J A,D'AMICO T A,ALMHANNA K,et al.Esophageal and esophagogastric junction cancers,version 1.2015[J].J Natl Compr Canc Netw,2015,13(2):194-227.
[7] VAN HAGEN P,HULSHOF M C,VAN LANSCHOT J J,et al.Preoperative chemoradiotherapy for esophageal or junctional cancer[J].N Engl J Med,2012,366(22):2074-2084.
[8] LORDICK F,MARIETTE C,HAUSTERMANS K,et al.Oesophageal cancer:ESMO clinical practice guidelines for diagnosis,treatment and follow-up[J].Ann Oncol,2016,27(suppl 5):v50-v57.
[9] CANCER GENOME ATLAS RESEARCH N,ANALYSIS WORKING GROUP:ASAN U,AGENCY BCC,et al.Integrated genomic characterization of oesophageal carcinoma[J].Nature,2017,541(7636):169-175.
[10] RODRIGUES-PINTO E,PEREIRA P,COELHO R,et al.Outcome and risk factors assessment for adverse events in advanced esophageal cancer patients after self-expanding metal stents placement[J].Dis Esophagus,2017,30(3):1-6.
[11] FUCCIO L,SCAGLIARINI M,FRAZZONI L,er al.Development of a prediction model of adverse events after stent placement for esophageal cancer[J].Gastrointest Endosc,2016,83(4):746-752.
[12] LECLEIRE S,DI FIORE F,BEN-SOUSSAN E,et al.Prior chemoradiotherapy is associated with a higher life-threatening complication rate after palliative insertion of metal stents in patients with oesophageal cancer[J].Aliment Pharmacol Ther,2006,23(12):1693-1702.
[13] HOMS M Y,HANSEN B E,VAN BLANKENSTEIN M,et al.Prior radiation and/or chemotherapy has no effect on the outcome of metal stent placement for oesophagogastric carcinoma[J].Eur J Gastroenterol Hepatol,2004,16(2):163-170.
[14] ALLUM W H,BLAZEBY J M,GRIFFIN S M,et al.Guidelines for the management of oesophageal and gastric cancer[J].Gut,2011,60(11):1449-1472. |